LRP5Low Density Lipoprotein Receptor-Related Protein 5
References in periodicals archive ?
Hem FZD4 hem LRP5 mutasyonlari olan AEVR hastalari bildirilmistir, ancak bu birlikteligin fenotipin agirlasmasina neden oldugu tanimlanmamistir.
Overview of the mutation spectrum in familial exudative vitreoretinopathy and Norrie disease with identification of 21 novel variants in FZD4, LRP5, and NDP.
Identification of FZD4 and LRP5 mutations in 11 of 49 families with familial exudative vitreoretinopathy.
Two LRP5 variants were found to have "modest" effects that were very consistent across different populations and independent of subject sex or age.
Members of the GENOMOS consortium--18 research teams in Europe and North America--performed prospective genotyping for several polymorphisms of the LRP5 gene that are thought to be related to osteoporosis.
Sclerostin, the protein product of SOST, is a circulating inhibitor of the Wnt-signaling pathway that achieves this by binding to LRP5 and LRP6 (56).
Identifying the molecules that bind to LRP5 is a high priority, he and Cohn agree.
Gerard Karsenty of the Baylor College of Medicine in Houston and his colleagues created mice with mutations in their LRP5 genes and found that the rodents developed osteoporosis and eye abnormalities.
It may be possible to develop a drug to activate LRP5 on osteoblasts, stimulating cells to strengthen bones and prevent or slow common osteoporosis, speculates Warman.
4] Human genes: COL1A1, collagen type 1, [alpha] 1; COL1A2, collagen type 1, [alpha] 2; LRP5, low-density lipoprotein receptor-related protein 5.
Wnt7b activates canonical signaling in epithelial and vascular smooth muscle cells through interactions with Fzd1, Fzd10, and LRP5.